Omada Health (OMDA) vs P3 Health Partners (PIII)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Omada Health (OMDA) has outperformed P3 Health Partners (PIII) over the past year, losing 36.2% versus a loss of 70.4%. Omada Health is the larger company by market cap ($736.4 million vs $350.2 million), about 2.1 times the size. Omada Health converts more of its revenue into profit, with a net margin of -4.9% versus -10.1%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | OMDA | PIII |
|---|---|---|
| Share price | $11.87 | $1.69 |
| Market cap | $736.39M | $350.24M |
| 1-day change | -5.04% | -9.14% |
| YTD return | -24.78% | -51.58% |
| 1-year return | -36.18% | -70.40% |
| 5-year return | — | -99.66% |
| P/E ratio (TTM) | 29.68 | — |
| Forward P/E | 17.18 | — |
| EPS (TTM) | $0.40 | $-23.21 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $260.21M | $1.46B |
| Revenue growth (YoY) | +53.24% | -2.76% |
| Net income (latest FY) | $-12.78M | $-147.95M |
| Gross margin | 65.69% | — |
| Operating margin | -4.60% | -18.53% |
| Net margin | -4.91% | -10.14% |
| 52-week high | $25.45 | $16.89 |
| 52-week low | $10.28 | $1.52 |
| Distance from 52-week high | -53.36% | -89.99% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +123.25% | +358.58% |
| Average volume | 1.33M | 30.85K |
| Shares outstanding | 62.04M | 4.02M |
| Employees | 980 | 320 |
| Sector | Health Care | Health Care |
| Industry | Medical/Nursing Services | Medical/Nursing Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Omada Health is about 2.1 times larger than P3 Health Partners by market value ($736.39M vs $350.24M).
- OMDA has outperformed PIII by 34.2 percentage points over the past year.
- Omada Health is more profitable, keeping -4.9 cents of every revenue dollar as net income versus -10.1 cents for P3 Health Partners.
- Omada Health grew revenue faster in its latest fiscal year (+53.24% vs -2.76%).
About Omada Health
OMDA stock →Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs.
Health Care · Medical/Nursing Services · 980 employees
About P3 Health Partners
PIII stock →P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers.
Health Care · Medical/Nursing Services · 320 employees
OMDA vs PIII FAQ
Which is bigger, Omada Health or P3 Health Partners?
Omada Health (OMDA) is larger, with a market capitalization of $736.39M compared with $350.24M for P3 Health Partners (PIII).
Which stock has performed better over the past year, OMDA or PIII?
OMDA returned -36.18% over the past 12 months, compared with -70.40% for PIII (price return, excluding dividends). Past performance does not predict future results.
Are Omada Health and P3 Health Partners in the same industry?
Yes. Both are classified in the Medical/Nursing Services industry within the Health Care sector.